Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir, Ledipasvir and Ribavirin for HCV Genotype 1 Cirrhosis
NCT02705534Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2016
- Primary completion
- Sep 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of sofosbuvir, ledipasvir, ribavirin in hepatitis C (HCV), sponsored by Tehran University of Medical Sciences. Started Sep 2016; status: completed.
02
Drugs
sofosbuvirledipasvirribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02705534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02705534.